A paradigm shift: emerging roles of microglia, a non-neuronal cell, in learning and memory
範式轉變：小膠質細胞（非神經元細胞）在學習和記憶中的新興作用
Neelima Gupta, S. Thameem Dheen | National University of Singapore, Singapore
Slc7a5 regulation of neural development
Slc7a5神經發育調控
Aidan M. Sokolov, David M. Feliciano | Clemson University, USA
MicroRNA-based therapeutics for optic neuropathy – opportunities and challenges
基於MicroRNA治療視神經病變–機遇與挑戰
Heather K. Mak, Christopher K. S. Leung | The Chinese University of Hong Kong, Hong Kong SAR, China
In vivo direct reprogramming as a therapeutic strategy for brain and retina repair
體內直接重編程作為腦和視網膜修復的治療策略
Haruka Sekiryu, Taito Matsuda | Kyushu University, Japan
Intravitreal fluorogold tracing as a method to label retinal neurons and the retinal pigment epithelium
玻璃體內氟金示蹤標記視網膜神經元和視網膜色素上皮
Francisco Javier Valiente-Soriano, Fernando Lucas-Ruiz, Juan A. Miralles de Imperial-Ollero, Manuel Vidal-Sanz, Marta Agudo-Barriuso | Universidad de Murcia, Spain
OTX2 signaling in retinal dysfunction, degeneration and regeneration
OTX2信號傳導在視網膜功能障礙、變性和再生中的作用
Kenneth. L. Moya, Raoul Torero Ibad | PSL Research University, France
Modulation of brainstem reflexes induced by non-invasive brain stimulation – Is there a future?
由非侵入性腦刺激引起的腦幹反射調節-有未來嗎？
Hatice Kumru, Markus Kofler, Josep Valls-Sole | Universitat Autònoma de Barcelona, Spain
High mobility group box-1 protein as a therapeutic target in perinatal hypoxic-ischemic brain injury
高遷移率族box-1蛋白作為圍產期缺氧缺血性腦損傷的治療靶標
Kazuki Hatayama, Barbara S. Stonestreet | Brown University, USA
Regulating autophagy: a novel role for SETX (Senataxin)
調節自噬：SETX（Senataxin）的新角色
Patricia Richard, Emanuel Rosonina | Therapeutics Inc., USA
Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
生物標記物指導的藥物療法：治療阿爾茨海默病的個性化藥物
Charvi Syal, Jing Wang | Ottawa Hospital Research Institute, Canada
How would preclinical Alzheimer’s disease (AD pathology) occur? An insight from a genomic instability mouse model
臨床前阿爾茨海默病（AD病理學）是如何發生的？基因組不穩定性小鼠模型的見解
Chinthalapally V. Rao, Hiroshi Y. Yamada | University of Oklahoma Health Sciences Center, USA
Short-chain fatty acids in the context of Parkinson’s disease
帕金森病背景下的短鏈脂肪酸
Judith Metzdorf, Lars Tönges | Ruhr-University Bochum, Germany
Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson’s disease?
非編碼RNA和幹細胞：帕金森病神經再生的理想團隊？
Shubhra Acharya, Andrew I. Lumley, Yvan Devaux | University of Luxembourg, Luxembourg
The dual role of necrostatin-1 in Parkinson’s disease models
Necrostatin-1在帕金森病模型中的雙重作用
Eva Alegre-Cortés, Guadalupe Martínez-Chacón, José M. Fuentes, Sokhna M. S. Yakhine-Diop | Universidad de Extremadura, Spain
Potential role of biofeedback therapy for Parkinson’s disease
生物反饋療法在帕金森病中的潛在作用
Naoya Kotani, Takashi Morishita, Tooru Inoue | Fukuoka University Faculty of Medicine, Japan
Pharmacological interventions targeting nuclear factor-kappa B signaling in multiple sclerosis
針對多發性硬化症中靶標NF-kB信號傳導的藥物幹預
Kim M. A. De Kleijn, Gerard J. M. Martens | Radboud University, The Netherlands
Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
海藻糖在神經退行性疾病中的治療潛力：已知和未知
Masoomeh Khalifeh, George E. Barreto, Amirhossein Sahebkar | University of Limerick, Ireland
Nuclear sphingomyelin in neurodegenerative diseases
核鞘磷脂在神經退行性疾病中的作用
Elisabetta Albi, Alice V. Alessenko | University of Perugia, Italy